Nanotechnology for Age-Related Macular Degeneration
Pharmaceutics, 2021 Age-related macular degeneration (AMD) is a degenerative eye disease that is the leading cause of irreversible vision loss in people 50 years and older.
Bo Yang +6 more
doaj +1 more source
Automated detection of age-related macular degeneration in color fundus photography:a systematic review [PDF]
, 2019 The rising prevalence of age-related eye diseases, particularly age-related macular degeneration, places an ever-increasing burden on health care providers.
Cameron, James +6 more
core +4 more sources
Detection of early age-related macular degeneration using novel functional parameters of the focal cone electroretinogram [PDF]
, 2014 The focal cone electroretinogram is a sensitive marker for macular disease, but have we unlocked its full potential? Typically assessment of waveform parameters is subjective and focuses on a small number of locations (e.g. the a-wave).
A Bird +46 more
core +15 more sources
Open innovation in neuroscience research and drug discovery
Brain and Neuroscience Advances, 2018 The pressures on the pharmaceutical industry have incentivised a number of new collaborative models of research and development which can be categorised as open innovation.
Ann J. Hunter, Wen H. Lee, Chas Bountra
doaj +1 more source
Y chromosome mosaicism is associated with age-related macular degeneration [PDF]
, 2019 Acknowledgements The authors thank Sudha K. Iyengar, Rob Igo and Alberto H. Santana (Case Western Reserve University, Cleveland, Ohio, USA) as well as the IAMDGC (http://eaglep.case.edu/iamdgc_web/) for providing the raw probe intensities.
on behalf of the International Age-related Macular Degeneration Genomics Consortium (IAMDGC)
core +1 more source
Macular Pigment Optical Density and its Determinants among Adults: A Cross-sectional Study [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Interplay exists between the risk factors of Agerelated Macular Degeneration (AMD) and the factors influencing Macular Pigment Optical Density (MPOD) level.
POOJA GOYAL +3 more
doaj +1 more source
Cost effectiveness of treatments for wet age-related macular degeneration [PDF]
, 2011 Age-related macular degeneration (AMD) is a leading cause of blindness in people aged >= 50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems.
Annemans, Lieven +4 more
core +1 more source
Optical Coherence Tomographic Angiography Imaging in Age-Related Macular Degeneration. [PDF]
, 2017 Optical coherence tomographic angiography (OCTA) is emerging as a rapid, noninvasive imaging modality that can provide detailed structural and flow information on retinal and choroidal vasculature.
Desai, Ria +5 more
core +3 more sources
Fatores de risco para degeneração macular relacionada à idade na Argentina [PDF]
, 2013 PURPOSES: To assess the risk factors of age-related macular degeneration in Argentina using a case-control study. METHODS: Surveys were used for subjects' antioxidant intake, age/gender, race, body mass index, hypertension, diabetes (and type of ...
Carter, Marissa Janine +10 more
core +2 more sources
RETINAL ANGIOMATOUS PROLIFERATION: A Quantitative Analysis of the Fundoscopic Features of the Fellow Eye [PDF]
, 2015 PURPOSE: To quantitatively analyze and compare the fundoscopic features between fellow eyes of retinal angiomatous proliferation and typical exudative age-related macular degeneration and to identify possible predictors of neovascularization. METHODS:
Costa, MA +6 more
core +1 more source